Treatment of colorectal liver metastases by cryotherapy

Seminars in Surgical Oncology

Volumn 14, Issue 2, 1998, Pages 163-170

  Weaver, M Lance ^a,b   Ashton, Jennifer G ^a   Zemel, Reuben ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Carcinoembr yonic antigen; Colorectal neoplasms; Cryotherapy; Liver neoplasms surgery complications mortality ultrasonography; Local neoplasm recurrence; Neoplasm metastases; Survival rate

Indexed keywords

ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; COLORECTAL CANCER; CRYOTHERAPY; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; CRYOSURGERY; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RECURRENCE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031932323     PISSN: 87560437     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2388(199803)14:2<163::AID-SSU8>3.0.CO;2-3     Document Type: Article

References (73)

1. Parker SL, Tong T, Bolden S, Wingo PA: Cancer statistics, 1997. CA Cancer J Clin 1997; 47:5-27.
2. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE: Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141:586-589.
3. Bengmark S, Hafstrom L: The natural history of primary and secondary malignant tumors of the liver. Cancer 1969; 25:198-202.
4. Oxley EM, Ellis H: Prognosis of carcinoma of the large bowel in the presence of liver metastases. Br J Surg 1969; 56:149-152.
5. Adson MA, Van Heerden JA, Adson MH, et al: Resection of hepatic metastases from colon cancer. Arch Surg 1984; 119: 647-651.
6. Kortz WJ, Meyers WC, Hanks JB, et al: Hepatic resection for metastatic cancer. Ann Surg 1984, 199:182-186.
7. Cady B, McDermott WV: Major hepatic resection for metachronous metastases from colon cancer. Ann Surg 1985; 201:204-209.
8. Hughes KS, Simon R, Songhorabodi S, et al: Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence. Surgery 1986; 100:278-284.
9. Ekberg H, Tranberg KG, Andersson R, et al: Pattern of recurrence in liver resection for colorectal secondaries. World J Surg 1987; 11:541-547.
10. Minton JP, Hamilton WB, Sardi A, et al: Results of surgical excision of one to 13 hepatic metastases in 98 consecutive patients. Arch Surg 1989; 124:46-48.
11. Vogt P, Raab R, Ringe B, Pichlmayr R: Resection of synchronous liver metastases from colorectal cancer. World J Surg 1991; 15:62-67.
12. Doci R, Gennari L, Bignami P, et al: One hundred patients with hepatic metastases from colorectal cancer treated by resection: analysis of prognostic determinants. Br J Surg 1991; 78:797-801.
13. Rosen CB, Nagomey DM, Taswell HF, et al: Preoperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992; 216:493-505.
14. Pedersen IK, Burcharth F, Roikjaer O, Baden H: Resection of liver metastases from colorectal cancer. Dis Colon Rectum 1994; 37:1078-1082.
15. Scheele J, Stangl R, Altendorf-Hofmann A, Paul M: Resection of colorectal liver metastases. World J Surg 1995, 19:59-71.
16. Buroker T Kim PN, Groppe C, et al. 5FU infusion with mitomycin-C versus 5FU infusion with methyl-CCNU in the treatment of advanced colon cancer. Cancer 1978; 42:1228-1233.
17. Petrelli N, Herrera L, Rustum Y, et al: A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leukovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma. J Clin Oncol 1987; 5:1559-1565.
18. Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Superiority of sequential methotrexate, fluorouracil, and leukovorin to fluorouracil alone in advanced symptomatic colorectal carcinoma: a randomized trial J Clin Oncol 1989; 7:1437-1446.
19. Advanced Colorectal Cancer Meta-analysis Project Modulation of fluorouracil by leukovorin in patients with advanced colorectal cancer: evidence in terms of response rate [comment in: J Clin Oncol 1993; 11.382-383]. J Clin Oncol 1993; 10:896-903.
20. Hill M, Norman A, Cunningham D, et al: Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer [comment in: J Clin Oncol 1995; 13:287-290]. J Clin Oncol 1995; 13:1297-1302.
21. Leichman CG, Fleming TR, Muggia FM, et al: Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study [comment in: J Clin Oncol 1995; 13:287-290]. J CIin Oncol 1995, 13:1303-1311.
22. Grage TB, Vassilopoulos PP, Shingleton WW, et al: Results of a prospective randomized study of hepatic artery infusion with 5 fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study. Surgery 1979; 86:550-555.
23. Balch CM, Urist MM, Soong SJ, McGregor M: A prospective phase II clinical trial of continuous FUDR regional chemotherapy for colorectal metastases to the liver using a totally implantable drug infusion pump. Ann Surg 1983; 198:567-573.
24. Kemeny N, Daly J, Oderman P, et al: Hepatic artery pump infusion: toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 1984; 2 595-600.
25. Shephard KV, Levin B, Karl RC, et al: Therapy for metastatic colorectal cancer width hepatic artery infusion chemotherapy using a subcutaneously implanted pump J Clin Oncol 1985; 3:161-169.
26. Chang AE, Schneider PD, Sugarbaker PH, et al: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases Ann Surg 1987; 206:686-693.
27. Poon MA, O'Connell MJ, Moertel CG, et al: Biochemical modulation of fluorouracil: evidence of significant improvement and quality of life in patients with advanced colorectal carcinoma. J Clin Oncol 1989; 7:1407-1418.
28. Hohn DC, Staggs RJ, Friedman MA, et al: A randomized trial of continuous intravenous versus hepatic arterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial. J Clin Oncol 1989; 7:1646-1654.
29. Doroshow JH, Multhauf P, Leong L, et al: Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous leukovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy. J Clin Oncol 1990; 8:491-501.
30. Kemeny N, Seiter K, Niedzwiecki D, et al: A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992; 69:327-334.
31. Rougier P, Laplanche A, Huguier M, et al: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10:1112-1118.
32. Kemeny N, Lockich JJ, Anderson N, Ahlgren JD: Recent advances in the treatment of advanced colorectal cancer. Cancer 1993; 71:9-18.
33. Kemeny N, Cohen A, Seiter K, et al: Randomized trial of hepatic artery floxuridine, mitomycin, and carmustine versus floxuridine alone in previously treated patients with liver metastases from colorectal cancer. J Clin Oncol 1993; 11:330-335.
34. Kemeny N, Conti JA, Sigurdson E, et al: A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leukovorin. Cancer 1993; 71: 1964-1971.
35. Hafstrom L, Engaras B, Holmberg SB, et al: Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. Cancer 1994; 74:2749-2756.
36. Kemeny N, Conti JA, Cohen A, et al: Phase II study of hepatic arterial floxuridine, leukovorin, and dexamethasone for unresectable liver metastases from colorectal carcinoma. J Clin Oncol 1994; 12:2288-2295.
37. Vauthey JN, Marsh RW, Cendan JC, et al: Arterial therapy of hepatic colorectal metastases. Br J Surg 1996; 83:447-455.
38. Ravikumar TS, Kane R, Cady B, et al: Hepatic cryosurgery with intraoperative ultrasound monitoring for metastatic colon carcinoma. Arch Surg 1987; 122:403-409.
39. Charnley RM, Doran J, Morris DL. Cryotherapy for liver metastases: a new approach Br J Surg 1989; 76:1040-1041.
40. Onik G, Rubinsky B, Zemel R, et al: Ultrasound-guided hepatic cryosurgery in the treatment of metastatic colon cancer. Cancer 1991; 67:901-907.
41. Ravikumar TS, Kane R, Cady B, et al: A 5-year study of cryosurgery in the treatment of liver tumors Arch Surg 1991; 126:1520-1523.
42. Onik GM, Atkinson D, Zemel R, Weaver ML: Cryosurgery of liver cancer. Semin Surg Oncol 1993; 9:1-9.
43. Polk W, Fong Y, Karpeh M, Blumgart LH: A technique for the use of cryosurgery to assist hepatic resection. J Am Col Surg 1995; 180 171-176.
44. Weaver ML, Atkinson D, Zemel R: Hepatic cryosurgery in treating colorectal metastases. Cancer 1995; 76:210-214.
45. Cuschieri A, Crostwaite G, Shimi S, et al: Hepatic cryotherapy for liver tumors. Surg Endosc 1995; 9:483-489.
46. Weaver ML, Atkinson D, Zemel R: Hepatic cryosurgery in the treatment of unresectable metastases. Surg Oncol 1995; 4:231-236.
47. Shafir M, Shapiro R, Sung M, et al: Cryoablation of unresectable malignant liver tumors. Am J Surg 1996, 171:27-31.
48. Adam R, Alpinar E, Johann M, et al: Place of cryosurgery in the treatment of malignant liver tumors. Ann Surg 1997; 225:39-50.
49. Korpan NN: Hepatic cryosurgery for liver metastases. Ann Surg 1997; 225:193-201.
50. Onik GM, Chambers N, Chernus SA, et al: Hepatic cryosurgery with and without the Bair Hugger. J Surg Oncol 1993; 52:185-187.
51. Tytus JS: Cryosurgery, its history and development. In Rand RW, Rinfert AP, Von Leden H (eds): "Cryosurgery." Springfield. IL: Charles C. Thomas; 1968, p. 3-18.
52. Cooper IS: Cryogenic surgery; a new method of destruction or extirpation of benign or malignant tumors. N Eng J Med 1963; 268:743-749.
53. Neel HB 3d, Ketcham AS, Hammond WG. Cryonecrosis of normal and tumor bearing rat liver potentiation by inflow occlusion. Cancer 1971; 28:1211-1218.
54. Grady ED, Nolan TR, Crumbley AJ: Cryotherapy of implanted cancer in rat liver. Oncology 1973; 28:104-109.
55. Zhou XD, Tang ZY, Yu YQ, et al: Clinical evaluation of cryosurgery in the treatment of primary liver cancer. Cancer 1988; 61:1889-1892
56. Dutta P, Montes M, Gage AA: Large volume freezing in experimental hepatic cryosurgery. Cryobiology 1979; 16:50-55.
57. Jacob G, Li KC, Hobbs KE: A comparison of cryodestruction with excision or infarction of an implanted tumor in rat liver. Cryobiology 1984; 21:148-156.
58. Igawa S, Sakai K, Kinoshita H, Hirohashi K: Intraoperative sonosraphy: clinical usefulness in liver surgery. Radiology 1985; 156:473-478.
59. Gilbert JC, Onik GM, Hoddick WK, Rubinsky B: The use of ultrasound for monitoring hepatic cryosurgery. Cryobiology 1985, 22:319-330.
60. Wood CB, Gillis CR, Blumgart LH: A retrospective study of the natural history of patients with liver metastases from colorectal cancer. Clin Oncol 1976; 2:285-288.
61. Cady B, Stone MD, McDermott WV, et al: Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg 1992; 127:561-569.
62. Fong Y, Kemeny N, Paty P, et al: Treatment of colorectal cancer: hepatic metastases. Semin Surg Oncol 1996; 12:219-252.
63. Creech O, Krementz ET, Ryan RF, et al: Chemotherapy of cancer regional perfusion utilizing an extracorporeal circuit. Ann Surg 1958; 148:616-632.
64. Ku Y, Saitoh M, Nishiyama H, et al: Extracorporeal removal of anticancer drugs in hepatic artery infusion: the effect of direct hemoperfusion combined with venovenous bypass. Surgery 1990; 107:273-281.
65. Ramming KP, Sparks FC, Eilber FR, et al: Hepatic artery ligation and 5-fluorouracil infusion for metastatic colon carcinoma and primary hepatoma. Am J Surg 1976; 132:236-242.
66. Berjian RA, Douglas HO, Nava HR, Karakousis C: The role of hepatic artery ligation and dearterialization with infusion chemotherapy in advanced malignancies in the liver. J Surg Oncol 1980; 14:379-387.
67. Petrelli NJ, Barcewicz PA, Evans JT, et al: Hepatic artery ligation for liver metastasis in colorectal carcinoma. Cancer 1984; 53: 1347-1353.
68. Preketes AP, King J, Caplehorn JR, et al: CEA reduction after cryotherapy for liver metastases from colon cancer predicts survival. Aust NZ J Surg 1994; 64:612-614.
69. O'Connell MJ, Adson MA, Schutt AJ, et al: Clinical trials of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mayo Clin Proc 1985; 60:517-520.
70. Preketes AP, Caplehorn JR, King J, et al: Effect of hepatic artery chemotherapy on survival of patients with hepatic metastases from colorectal carcinoma treated with cryotherapy. World J Surg 1995; 19:768-771.
71. Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP: Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110:13-29.
72. Nordlinger B, Parc R, Delva E, et al: Hepatic resection for colorectal liver metastases. Ann Surg 1987; 205:256-263.
73. Fortner JG, Silva JS, Cox EB, et al: Multi-variate analysis of a personal series of 247 patients with liver metastases from colorectal cancer. Ann Surg 1984; 199:306-316.